Enhanced MCP-1 Release in Early Autosomal Dominant Polycystic Kidney Disease

Peter Janssens1,2, Jean-Paul Decuypere1, Stéphanie De Rechter1

  • 1PKD Research Group, Laboratory of Pediatrics, Department of Development and Regeneration, KU Leuven, Leuven, Belgium.

Insights

Monocyte chemoattractant protein-1 (MCP-1) is elevated in children with autosomal dominant polycystic kidney disease (ADPKD). This finding suggests MCP-1 is an early biomarker for ADPKD severity and a potential therapeutic target.

Area of Science:

  • Nephrology
  • Pediatric Nephrology
  • Molecular Biology

Background:

  • Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder leading to kidney failure.
  • While ADPKD manifests in adulthood, its origins are in utero.
  • Biomarkers like copeptin, EGF, and MCP-1 are linked to adult ADPKD severity but are unstudied in early disease stages.

Purpose of the Study:

  • To investigate early-stage biomarkers in pediatric ADPKD.
  • To assess plasma copeptin, urinary EGF, and urinary MCP-1 in children with ADPKD.
  • To explore the role of MCP-1 in ADPKD pathogenesis.

Main Methods:

  • Cross-sectional study comparing pediatric ADPKD patients and healthy controls.
  • Measurement of plasma copeptin, urinary EGF, and urinary MCP-1.
  • In vitro studies using mouse and human kidney cells, and analysis of fetal kidney tissue.

Main Results:

  • Urinary MCP-1 levels were significantly higher in ADPKD patients compared to controls.
  • Plasma copeptin and urinary EGF levels were comparable between groups.
  • Increased MCP-1 secretion was observed in mutated human tubular cells and knockout mouse cells, with elevated MCP-1 and M2 macrophage infiltration in fetal ADPKD kidneys.

Conclusions:

  • Elevated tubular MCP-1 secretion is an early event in ADPKD.
  • MCP-1 serves as an early marker for ADPKD disease severity.
  • MCP-1 represents a potential therapeutic target for ADPKD.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
297
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
4.3K
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
4.7K